Medical Facilities Corporation
TSX:DR.TOMedical - Care Facilities
+$0.18 today
- Market cap
- $282.59M
- Beta
- 0.34
- P/E (TTM)
- 8.7
- EPS (TTM)
- $1.47
- Dividend yield
- 2.00%
Volume 0.04M
Average 0.02M
DR.TO Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Medical Facilities CorporationTSX: DR.TO
Operating Margin · Q1 FY2026 · quarter ended Mar 2026
Operating margin widens to 18.5%
Operating margin was 18.5% in Q1 FY2026, up 2.5 pp from a year earlier. On a trailing-twelve-month basis it was 17.7%, down 1.0 pp year over year. Over 3 fiscal years it widened by 10.1 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 1 analysts of 22.8% for the fiscal year ending Dec 2026, up from 18.4% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 18.5%-4.9 pp QoQ
- Last fiscal yearDec 2025
- 18.4%-0.2 pp YoY
- LTMMar 2026
- 17.7%-1.0 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +2.5 pp | -7.1 pp | -9.6 pp |
| 1 year | -0.2 pp | +4.4 pp | +4.7 pp |
| 3 years | +10.1 pp | +1.8 pp | -8.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 18.4%
- Year-over-year change
- -0.2pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.4% | -0.2pp |
| FY2024 | 2024-12-31 | 18.6% | +3.5pp |
| FY2023 | 2023-12-31 | 15.1% | +6.8pp |
| FY2022 | 2022-12-31 | 8.2% | -11.2pp |
| FY2021 | 2021-12-31 | 19.4% | — |
Operating Margin vs competitors
How DR.TO compares with its peers on the latest reported figures
- DR.TO's LTM Mar 2026 operating margin of 17.7% is the highest of the 8 companies compared; the peer median is -11.9%.
- Its year-over-year change of -1.0 pp is the 5th highest of 8, against a peer median of +1.9 pp.
- Over three fiscal years its change of +10.1 pp compares with a peer median of +83.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 17.7% | -1.0 pp | +10.1 pp | |
| LTM Mar 2026 | 16.8% | +21.8 pp | +26.7 pp | |
| LTM Mar 2026 | 13.5% | -4.4 pp | +73.4 pp | |
| LTM Mar 2026 | 3.2% | +1.9 pp | +9.0 pp | |
| LTM Mar 2026 | -11.9% | +26.8 pp | +1457.4 pp | |
| LTM Mar 2026 | -23.5% | +20.0 pp | +93.1 pp | |
| LTM Mar 2026 | -38.6% | -26.4 pp | — | |
PRN.TOProfound Medical Corp. | LTM Mar 2026 | -202.5% | -17.5 pp | +186.8 pp |
| FY2025 | — | — | — | |
| Peer median (excluding DR.TO) | -11.9% | +1.9 pp | +83.2 pp | |
Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 398.63M | 424.55M | 445.58M | 331.53M | 258.62M |
| Cost of Revenue | 130.03M | 143.93M | 148.9M | 111.65M | 160.42M |
| Gross Profit | 268.61M | 280.63M | 296.68M | 219.88M | 98.2M |
| Gross Margin | 67.4% | 66.1% | 66.6% | 66.3% | 38.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 177.58M | 198.21M | 151.73M | 151.12M | 119.23M |
| Operating Expenses | 191.25M | 245.69M | 229.57M | 158.24M | 50.72M |
| Depreciation & Amortization | 26.77M | 20.76M | 21.54M | 19.37M | 11.94M |
| EBITDA | 103.4M | 51.15M | 72.43M | 82.57M | 59.41M |
| EBITDA Margin | 25.9% | 12.0% | 16.3% | 24.9% | 23.0% |
| Operating Income | 77.36M | 34.94M | 67.11M | 61.64M | 47.47M |
| Operating Margin | 19.4% | 8.2% | 15.1% | 18.6% | 18.4% |
| Interest Income | 76K | 8.54M | 717K | 1.87M | 2.24M |
| Interest Expense | 25.74M | 12.89M | 16.5M | 12.09M | 3.59M |
| Other Income / Expenses | (26.47M) | (17.44M) | (14.27M) | (10.53M) | (7.19M) |
| Income Before Tax | 50.89M | 17.5M | 52.32M | 51.11M | 40.28M |
| Pre-Tax Margin | 12.8% | 4.1% | 11.7% | 15.4% | 15.6% |
| Income Tax Expense | 4.4M | 5.21M | 8.33M | (5.69M) | 5.06M |
| Net Income | 15.5M | (4.41M) | 18.5M | 73.49M | 21.08M |
| Net Margin | 3.9% | -1.0% | 4.2% | 22.2% | 8.2% |
| EPS (Basic) | 1.50 | 0.42 | 0.73 | 1.03 | 1.09 |
| EPS (Diluted) | 1.49 | 0.42 | 0.73 | 1.03 | 1.09 |
| Weighted Avg Shares | 31.09M | 29.37M | 25.35M | 18.5M | 19.48M |
| Weighted Avg Shares (Diluted) | 31.13M | 29.37M | 25.25M | 24M | 19.48M |
Medical Facilities Corporation
TSX:DR.TO
Intrinsic Alpha fair value
Locked
Current Price
$17.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.